Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 70.65M
March 31, 2026 70.63M
December 31, 2025 70.61M
September 30, 2025 70.54M
June 30, 2025 70.48M
March 31, 2025 70.10M
December 31, 2024 70.10M
September 30, 2024 69.95M
June 30, 2024 69.86M
March 31, 2024 54.86M
December 31, 2023 49.63M
September 30, 2023 49.63M
June 30, 2023 49.59M
March 31, 2023 49.52M
December 31, 2022 49.32M
September 30, 2022 49.22M
June 30, 2022 49.14M
March 31, 2022 49.03M
December 31, 2021 48.89M
September 30, 2021 48.73M
June 30, 2021 48.46M
March 31, 2021 38.22M
December 31, 2020 38.22M
September 30, 2020 38.22M
June 30, 2020 38.14M
Date Value
March 31, 2020 38.14M
December 31, 2019 38.14M
September 30, 2019 38.14M
June 30, 2019 38.10M
March 31, 2019 33.91M
December 31, 2018 33.91M
September 30, 2018 33.91M
June 30, 2018 33.85M
March 31, 2018 33.85M
December 31, 2017 33.85M
September 30, 2017 31.28M
June 30, 2017 31.23M
March 31, 2017 31.23M
December 31, 2016 31.23M
September 30, 2016 31.23M
June 30, 2016 31.19M
March 31, 2016 31.19M
December 31, 2015 28.59M
September 30, 2015 28.59M
June 30, 2015 28.59M
March 31, 2015 28.59M
December 31, 2014 28.52M
September 30, 2014 28.48M
June 30, 2014 28.48M
March 31, 2014 28.48M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Olin Corp. 114.00M
Stepan Co. 22.73M
Ascent Industries Co. 9.010M
BioLargo, Inc. 325.23M
The Chemours Co. 150.46M